A comparative study of atenolol and penbutolol in hypertensive patients.

Abstract	In a randomized controlled, double-blind clinical trial with 45 patients with moderate hypertension atenolol 100 mg and penbutolol 40 mg were equally effective in lowering the blood pressure. During the 6 weeks of treatment there was no change in body weight and serious side-effects were not observed, but bradycardia occurred more frequently with atenolol than with penbutolol. Withdrawal of medication during the final week of the study did not cause any adverse reaction.
Authors	L D Lameijer, J J Houtzagers, L A Voermans
Journal	European heart journal (Eur Heart J) Vol. 4 Suppl D Pg. 53-6 (Jul 1983) ISSN: 0195-668X [Print] England
PMID	6352272 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References	Propanolamines Atenolol Penbutolol
Topics	Adult Atenolol (therapeutic use) Blood Pressure Clinical Trials as Topic Diastole Double-Blind Method Female Humans Hypertension (drug therapy) Male Middle Aged Penbutolol (therapeutic use) Propanolamines (therapeutic use) Pulse Systole

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!